Diet for Hypoglycemia

Hypoglycemia News

Higher case volume associated with better outcomes of cardiac surgery: StudyFriday, July 30, 2010 @ 7:38AMA new analysis led by researchers at UCSF shows that avoiding lowest-volume hospitals and maximizing adherence to quality care processes are both effective approaches to reducing costs associated with coronary bypass surgery.

Sensor implant monitors sugar levelsWednesday, July 28, 2010 @ 5:08PMAn implantable sensor that continuously monitors glucose levels has worked for more than a year in a pig, raising hopes for use in people with diabetes, researchers report.

Adding Noninsulin Antidiabetic Drugs to Metformin Therapy for Type 2 Diabetes [Letters]Tuesday, July 27, 2010 @ 3:47PMTo the Editor: The clinical review by Dr Phung and colleagues 1 showed that the different classes of noninsulin antidiabetic drugs added to metformin therapy in type 2 diabetes provided similar reduction in hemoglobin A 1c (HbA 1c ) compared with placebo.

Adding Noninsulin Antidiabetic Drugs to Metformin Therapy for Type 2 Diabetes [Letters]Tuesday, July 27, 2010 @ 3:46PMTo the Editor: Dr Phung and colleagues 1 presented a meta-analysis of the effectiveness of several classes of antidiabetic agents used in combination with metformin, examining the effects on glycemic control, body weight, and hypoglycemia.

New technology can give diabetics greater freedomThursday, July 22, 2010 @ 12:59PMNo description available

Health CalendarThursday, July 22, 2010 @ 4:28AMFitness

Health CalendarThursday, July 22, 2010 @ 4:12AMAdventist Paulson Rehab Network , 619 Plainfield Road, Willowbrook, offers different fitness and exercise regimens including pre and post natal exercise, pool class, advanced circuit training program, keep it moving small group exercise class, arthritis foundation aquatic program, aquatic exercise classes and therapeutic massage.

Amylin Pharmaceuticals Reports Second Quarter Financial ResultsWednesday, July 21, 2010 @ 3:05PMAmylin Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million.

AMRI initiates enrollment for Phase I study of ALB-127158 for obesityWednesday, July 21, 2010 @ 8:08AMAMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also ...